ARTICLE | Clinical News
Ampakines regulatory update
January 29, 2001 8:00 AM UTC
The University of California at Irvine received U.S. Patent No. 6,166,008 covering Ampakines and other compounds that are positive modulators of the AMPA receptor for use in treating schizophrenia in...